Current language:
- FR Français
The translation of this page has been generated by machine translation.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Réponse de l’Agence européenne des médicaments (EMA) à la lettre de la Médiatrice européenne sur le rôle de l’EMA et de son groupe de travail sur la pandémie pendant la crise de la COVID-19
Correspondence - Date Wednesday | 30 September 2020
Case SI/5/2020/DDJ - Opened on Wednesday | 29 July 2020 - Decision on Monday | 08 March 2021 - Institution concerned European Medicines Agency - Country France
Veuillez télécharger le document pdf ci-joint.